Nicoletti Rosario, Trincone Antonio
Council for Agricultural Research and Agricultural Economy Analysis, Rome 00184, Italy.
Institute of Biomolecular Chemistry, National Research Council, Pozzuoli 80078, Italy.
Mar Drugs. 2016 Feb 18;14(2):37. doi: 10.3390/md14020037.
In recent years, the search for novel natural compounds with bioactive properties has received a remarkable boost in view of their possible pharmaceutical exploitation. In this respect the sea is entitled to hold a prominent place, considering the potential of the manifold animals and plants interacting in this ecological context, which becomes even greater when their associated microbes are considered for bioprospecting. This is the case particularly of fungi, which have only recently started to be considered for their fundamental contribution to the biosynthetic potential of other more valued marine organisms. Also in this regard, strains of species which were previously considered typical terrestrial fungi, such as Penicillium and Talaromyces, disclose foreground relevance. This paper offers an overview of data published over the past 25 years concerning the production and biological activities of secondary metabolites of marine strains belonging to these genera, and their relevance as prospective drugs.
近年来,鉴于新型天然化合物可能的药物开发价值,对具有生物活性的新型天然化合物的研究得到了显著推动。在这方面,海洋理应占据突出地位,考虑到在这种生态环境中相互作用的众多动植物的潜力,若将其相关微生物纳入生物勘探,这种潜力会更大。真菌尤其如此,直到最近人们才开始认识到它们对其他更具价值的海洋生物生物合成潜力的重要贡献。同样在这方面,以前被认为是典型陆生真菌的物种,如青霉属和篮状菌属的菌株,也显示出重要意义。本文概述了过去25年中发表的有关这些属的海洋菌株次生代谢产物的产生、生物活性及其作为潜在药物的相关性的数据。